World Journal of Urology

, Volume 32, Issue 1, pp 221–228 | Cite as

Urinary functional outcomes in female neobladder patients

  • Georg Bartsch
  • Siamak Daneshmand
  • Eila C. Skinner
  • Sumeet Syan
  • Donald G. Skinner
  • David F. Penson
Original article



The ratio between orthotopic and non-orthotopic diversions in women is far lower than in male patients. Data on urinary function in female patients with neobladders are therefore sparse.


We investigated the urinary function of female neobladder patients utilizing the Bladder Cancer Index, a validated and reliable health-related quality-of-life (HRQOL) questionnaire. Furthermore, we tried to identify preoperative factors that may influence functional results. All living female patients with an orthotopic neobladder (N = 82) from the University of Southern California Bladder Cancer Database were sent a questionnaire including the University of Michigan Bladder Cancer Index. Univariate analyses were performed using the Kruskal–Wallis test followed by a multivariate stepwise regression model.


Fifty-six patients (68.3 %) responded and were included in the analysis. Thirty-five (62.5 %) of these patients had to catheterize their neobladder to a certain amount, while 25 patients (44.6 %) depend on catheterization to empty their neobladder. Univariate analyses showed that patient age (>65 years) was the only variable associated with a statistically significant lower rate of neobladder catheterization. Better urinary bother scores were associated with organ-confined disease (p = 0.038) and education level (p = 0.01). However, these variables were not significant in a multivariate stepwise linear regression model.


Considerably more women require urinary catheterization to void than previously reported. In this study, representing the largest investigated cohort in this topic, we were unable to identify any predictors of this outcome or any other urinary HRQOL in this cohort.


Female Bladder cancer Urinary diversion Neobladder Urinary function 


Conflict of interest

All authors of this manuscript declare that they have no conflict of interest.


  1. 1.
    Yossepowitch O, Dalbagni G, Golijanin D, Donat SM, Bochner BH, Herr HW, Fair WR, Russo P (2003) Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. J Urol 169(1):177–181PubMedCrossRefGoogle Scholar
  2. 2.
    Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675PubMedGoogle Scholar
  3. 3.
    Gore JL, Saigal CS, Hanley JM, Schonlau M, Litwin MS (2006) Variations in reconstruction after radical cystectomy. Cancer 107(4):729–737PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Hobisch A, Tosun K, Kinzl J, Kemmler G, Bartsch G, Holtl L, Stenzl A (2001) Life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. Semin Urol Oncol 19(1):18–23PubMedGoogle Scholar
  5. 5.
    Fujisawa M, Isotani S, Gotoh A, Okada H, Arakawa S, Kamidono S (2000) Health-related quality of life with orthotopic neobladder versus ileal conduit according to the SF-36 survey. Urology 55(6):862–865PubMedCrossRefGoogle Scholar
  6. 6.
    Salinas Sanchez AS, Segura Martin M, Lorenzo Romero JG, Hernandez Millan I, Fernandez Olano C, Virseda Rodriguez JA (2001) Quality of life of patients after radical surgery of bladder cancer. Arch Esp Urol 54(8):787–795PubMedGoogle Scholar
  7. 7.
    Dutta SC, Chang SC, Coffey CS, Smith JA Jr, Jack G, Cookson MS (2002) Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol 168(1):164–167PubMedCrossRefGoogle Scholar
  8. 8.
    Daneshmand S, Bartsch G (2011) Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. Expert Rev Anticancer Ther 11(6):941–948PubMedCrossRefGoogle Scholar
  9. 9.
    Gilbert SM, Wood DP, Dunn RL, Weizer AZ, Lee CT, Montie JE, Wei JT (2007) Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI). Cancer 109(9):1756–1762PubMedCrossRefGoogle Scholar
  10. 10.
    Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRefGoogle Scholar
  11. 11.
    Cookson MS, Dutta SC, Chang SS, Clark T, Smith JA Jr, Wells N (2003) Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. J Urol 170(5):1926–1930PubMedCrossRefGoogle Scholar
  12. 12.
    Cella D, Neubauer N, Thomas J, Kutner J, Seiden MV (2013) The FACIT-AI, a new tool for assessing symptoms associated with malignant ascites. Gynecol Oncol 128(2):187–190PubMedCrossRefGoogle Scholar
  13. 13.
    Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG (2009) Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. J Urol 181(5):2052–2058PubMedCrossRefGoogle Scholar
  14. 14.
    Schrier BP, Laguna MP, van der Pal F, Isorna S, Witjes JA (2005) Comparison of orthotopic sigmoid and ileal neobladders: continence and urodynamic parameters. Eur Urol 47(5):679–685PubMedCrossRefGoogle Scholar
  15. 15.
    Stein JP, Skinner DG (2006) Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol 24(3):296–304PubMedCrossRefGoogle Scholar
  16. 16.
    Hautmann RE, Volkmer BG, Schumacher MC, Gschwend JE, Studer UE (2006) Long-term results of standard procedures in urology: the ileal neobladder. World J Urol 24(3):305–314PubMedCrossRefGoogle Scholar
  17. 17.
    Lee LJ, Chen CH, Yao G, Chung CW, Sheu JC, Lee PH, Tsai YJ, Wang JD (2007) Quality of life in patients with hepatocellular carcinoma received surgical resection. J Surg Oncol 95(1):34–39PubMedCrossRefGoogle Scholar
  18. 18.
    Ahmadi H, Skinner EC, Simma-Chiang V, Miranda G, Cai J, Penson DF, Daneshmand S (2013) Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients. J Urol 189(5):1782–1788PubMedCrossRefGoogle Scholar
  19. 19.
    Granberg CF, Boorjian SA, Crispen PL, Tollefson MK, Farmer SA, Frank I, Blute ML (2008) Functional and oncological outcomes after orthotopic neobladder reconstruction in women. BJU Int 102(11):1551–1555PubMedCrossRefGoogle Scholar
  20. 20.
    Park JM, Montie JE (1998) Mechanisms of incontinence and retention after orthotopic neobladder diversion. Urology 51(4):601–609PubMedCrossRefGoogle Scholar
  21. 21.
    Bhatta Dhar N, Kessler TM, Mills RD, Burkhard F, Studer UE (2007) Nerve-sparing radical cystectomy and orthotopic bladder replacement in female patients. Eur Urol 52(4):1006–1014PubMedCrossRefGoogle Scholar
  22. 22.
    Kessler TM, Studer UE, Burkhard FC (2007) Increased proximal urethral sensory threshold after radical pelvic surgery in women. Neurourol Urodyn 26(2):208–212PubMedCrossRefGoogle Scholar
  23. 23.
    Simon J, Bartsch G Jr, Kufer R, Gschwend JE, Volkmer BG, Hautmann RE (2006) Neobladder emptying failure in males: incidence, etiology and therapeutic options. J Urol 176(4 Pt 1):1468–1472PubMedCrossRefGoogle Scholar
  24. 24.
    Kubler H, Gschwend JE (2011) Ileal neobladder in women with bladder cancer: cancer control and functional aspects. Curr Opin Urol 21(6):478–482PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Georg Bartsch
    • 1
    • 2
  • Siamak Daneshmand
    • 1
  • Eila C. Skinner
    • 3
  • Sumeet Syan
    • 1
  • Donald G. Skinner
    • 1
  • David F. Penson
    • 4
  1. 1.Institute of UrologyUSC/Norris Comprehensive Cancer Center, University of Southern CaliforniaLos AngelesUSA
  2. 2.Department of UrologyGoethe UniversityFrankfurtGermany
  3. 3.Department of UrologyStanford UniversityPalo Alto, StanfordUSA
  4. 4.Department of Urologic Surgery, Center of Surgical Quality and Outcomes ResearchVanderbilt UniversityNashvilleUSA

Personalised recommendations